Mira Pharmaceuticals Inc
MIRA1.570USD
+0.030+1.95%
Close 08/04, 16:00（ET）Quotes delayed by 15 min
1.560USD+1.560After-hours (ET)
26.40MMarket Cap
LossP/E TTM
Mira Pharmaceuticals Inc
1.570
+0.030+1.95%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q1
FY2021Q1
Operating cash flows (indirect method)
Cash flow from continuing operating activities
-55.31%-1.63M
-74.40%-1.81M
-4.59%-1.84M
-30.74%-863.93K
2.40%-1.05M
---1.04M
---1.76M
---660.81K
47.35%-1.08M
-12337.16%-2.04M
---16.42K
Net income from continuing operations
-3.84%-1.78M
58.54%-2.40M
43.03%-2.04M
-33.58%-1.69M
-28.09%-1.72M
---5.79M
---3.59M
---1.27M
9.08%-1.34M
-2488.94%-1.48M
---56.98K
Other non-cash items
----
----
----
----
----
--250.00K
--439.38K
--292.92K
----
----
----
Change in working capital
-529.14%-721.06K
-94.10%47.88K
-68.87%-67.25K
152.03%222.59K
44.49%168.03K
--811.74K
---39.83K
---427.79K
120.35%116.28K
-1703.58%-571.37K
--35.63K
-Change in receivables
----
100.00%0.00
--0.00
--0.00
--11.86K
---11.86K
----
----
----
----
----
-Change in prepaid expenses
-277.68%-103.88K
177.69%31.84K
113.76%22.05K
338.19%76.71K
197.39%58.47K
---40.98K
---160.29K
--17.51K
---60.03K
----
----
-Change in payables and accrued expense
-731.72%-617.18K
-96.45%30.52K
-174.13%-89.31K
132.76%145.88K
-44.59%97.70K
--859.09K
--120.47K
---445.30K
131.16%176.32K
-1688.14%-565.87K
--35.63K
-Change in other current assets
----
----
----
----
----
--5.50K
--0.00
--0.00
100.00%0.00
---5.50K
--0.00
Cash from non-recurring investing activities
Cash from operating activities
-55.31%-1.63M
-74.40%-1.81M
-4.59%-1.84M
-30.74%-863.93K
2.40%-1.05M
---1.04M
---1.76M
---660.81K
47.35%-1.08M
-12337.16%-2.04M
---16.42K
Investing cash flow
Cash from non-current investing activities
Financing cash flow
Cash flow from continuous financing activities
113.89%3.38K
313.83%493.40K
-58.41%3.16M
-76.76%159.01K
-103.35%-24.34K
---230.75K
--7.60M
--684.29K
-46.47%725.68K
7926.07%1.36M
--16.89K
Net cash flow from debt Issuance/repayment
----
----
---14.47K
----
-100.00%0.00
--1.14M
--0.00
---219.54K
272.96%86.48K
-225.00%-50.00K
--40.00K
Net cash flow from common stock issuance/repurchase
--3.38K
136.55%493.40K
-65.44%3.13M
----
----
---1.35M
--9.05M
--0.00
-100.00%0.00
--1.58M
--0.00
Net cash flow from other financing activities
----
100.00%0.00
103.29%47.74K
-82.41%159.01K
-103.81%-24.34K
---19.15K
---1.45M
--903.83K
458.62%639.20K
-671.32%-178.24K
---23.11K
Net cash from non-recurrent financing activities
Net cash from financing activities
113.89%3.38K
313.83%493.40K
-58.41%3.16M
-76.76%159.01K
-103.35%-24.34K
---230.75K
--7.60M
--684.29K
-46.47%725.68K
7926.07%1.36M
--16.89K
Net cash flow
Beginning cash balance
-38.45%2.83M
-29.37%4.14M
11275.66%2.82M
261478.58%3.53M
1211.35%4.60M
--5.87M
--24.82K
--1.35K
-87.51%350.98K
80379.86%2.81M
--3.49K
Current period cash flow changes
-51.47%-1.63M
-3.62%-1.31M
-77.40%1.32M
-3102.96%-704.91K
-207.15%-1.07M
---1.27M
--5.84M
--23.47K
49.09%-349.63K
-146537.31%-686.79K
--469.00
Ending cash balance
-65.81%1.21M
-38.45%2.83M
-29.37%4.14M
11275.66%2.82M
261478.58%3.53M
--4.60M
--5.87M
--24.82K
-99.94%1.35K
53505.08%2.12M
--3.96K
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
